Visit our new Alternative Investment section.Click here

Less Ads, More Data, More Tools Register for FREE

IN BRIEF: IQ-AI amends distribution deal with Blackford Analysis

Mon, 03rd Feb 2025 19:22

IQ-AI Ltd - London-based medical services company - Amends existing distribution agreement with artificial intelligence platform provider Blackford Analysis Ltd. The amendment adds IB Nimble, IB ASL, IB FTB, and IB FTB Express to the agreement, allowing Blackford to also sell these products to their global client base. Acquired by Bayer in early 2023, Blackford operates in the healthcare AI platform and solutions sphere.

Current stock price: 1.66 pence

12-month change: down 42%

By Jeremy Cutler, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.


Shares in this article

Related News

IN BRIEF: IQ-AI applies for breakthrough therapy designation for GaM
2 May 2025

IN BRIEF: IQ-AI applies for breakthrough therapy designation for GaM

IQ-AI Ltd - London-based medical services company - Says subsidiary Imaging Biometrics LLC has applied for breakthrough therapy designation from the U...

IN BRIEF: IQ-AI to take GaM to phase II study, flags AI capabilities
22 Jan 2025

IN BRIEF: IQ-AI to take GaM to phase II study, flags AI capabilities

IQ-AI Ltd - London-based medical services company - Provides operations update focusing on artificial intelligence. Explains radiology leads the way i...

IN BRIEF: Braveheart buys 30% stake in IQ-AI from Braveheart CEO Brown
14 Oct 2024

IN BRIEF: Braveheart buys 30% stake in IQ-AI from Braveheart CEO Brown

IQ-AI Ltd - parent of Wisconsin-based Imaging Biometrics LLC, which provides quantitative imaging platforms and therapeutics for the diagnosis and tre...